Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-447P (RNA, U6 small nuclear 447, pseudogene) is a pseudogene related to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a crucial component of the spliceosome, a ribonucleoprotein complex responsible for splicing precursor mRNA in eukaryotes. The U6 snRNA gene is highly conserved, and vertebrate genomes often contain multiple U6-derived pseudogenes. Unlike functional U6 snRNA genes, RNU6-447P is not actively transcribed or involved in splicing. Most pseudogenes do not produce functional transcripts or proteins; however, some may influence gene regulation in rare cases by antisense RNA or miRNA decoy effects. There is no evidence that RNU6-447P possesses such activity or disease association. It is not a pharmacological or therapeutic target, nor a biomarker. The gene entry is supported in genetic databases and correctly named, but its relevance to therapeutics or molecular pharmacology is limited to fundamental genomic annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 447, pseudogene (RNU6-447P).